LENSAR Q4 revenue $16.7M (+38% YoY); positive Adj. EBITDA; ALLY placements surge

LENSAR, Inc.

2024-FY EPS reported -$2.73 revenue$53,494,000

Q4 revenue $16.7M, up 38% YoY; full-year revenue +27% YoY to ~$54M (implied).
Net loss $18.7M ($1.61/sh) driven by $17.6M warrant liability charge; Adjusted EBITDA positive $0.5M.
Placed 31 ALLY systems in Q4; total installed base ~385 (+26% YoY); 80+ ALLY placements in 2024.
Recurring revenue exceeded $40M in 2024 (+23% YoY); U.S. procedure market share >20% first time.
Worldwide procedure volumes grew 24% to nearly 170,000 in 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.